Vitrolife AB operates within the Surgical appliances and supplies sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vitrolife AB with three other
medical equipment manufacturers in Europe:
Medartis Holding AG
sales of 121.32 million Swiss Francs [US$122.80 million]
of which 55%
IVF Hartmann Holding AG
(133.38 million Swiss Francs [US$135.00 million]
of which 37%
was Infections Management), and
Amplitude Surgical SA
based in France
(100.34 million Euro [US$110.99 million]
of which 73%
During the year ended December of 2018, sales at
Vitrolife AB were SEK 1.15 billion (US$120.76 million).
increase of 10.0%
versus 2017, when the company's sales were SEK 1.05 billion.
This was the fifth consecutive year of sales increases at Vitrolife AB
(and since 2013, sales have increased a total of 154%).